Comparison of the Number of Leukocytes, Lymphocytes, Monocytes, and Neutrophils in Patients With Typhoid Fever and Dengue Fever
Perbandingan Jumlah Leukosit, Limfosit, Monosit, dan Neutrofil pada Pasien Demam Tifoid dan Demam Dengue
DOI:
https://doi.org/10.21070/ups.7748Keywords:
typhoid fever, Dengue Fever, leukocyte, lymphocytes, Monocytes, NeutrophilsAbstract
Dengue and typhoid are common infectious diseases in tropical regions like Indonesia. Dengue is caused by the dengue virus and transmitted through Aedes aegypti mosquito bites, with symptoms including high fever and muscle pain. Typhoid is caused by Salmonella typhi bacteria, spread through contaminated food or water. This study aimed to compare the number of leukocytes, lymphocytes, monocytes, and neutrophils in dengue and typhoid patients. A laboratory experimental method with a quantitative approach was used, involving 30 samples of patients aged 5–20 years for each group. Data analysis using the Independent T Test showed a significant difference in leukocyte count (p=0.145) and monocyte count (p=0.031), but not in lymphocytes (p=0.731) or neutrophils (p=0.987). In conclusion, only the monocyte count showed a significant difference between dengue and typhoid patients.
Downloads
References
R. Angriany, “Hubungan Nilai Neutrofil Limfosit Rasio (NLR) Dan C-Reactive Protein (CRP) Terhadap Derajat Keparahan Pasien Coronavirus Disease 2019 (COVID-19),” 2019.
A. T. Idhayu, L. K. Chen, S. Suhendro, and M. Abdullah, “Perbedaan Kadar C-Reactive Protein pada Demam Akut karena Infeksi Dengue dan Demam Tifoid,” J. Penyakit Dalam Indones., vol. 3, no. 3, p. 138, Jan. 2017, doi: 10.7454/jpdi.v3i3.24.
F. Ulfa and O. W. K. Handayani, “Kejadian Demam Tifoid di Wilayah Kerja Puskesmas Pagiyanten,” HIGEIA J. Public Health Res. Dev., vol. 2, no. 2, pp. 227–238, Apr. 2018, doi:
15294/higeia.v2i2.17900.
A. S. Sholihah, I. G. A. N. Danuyanti, S. Zaetun, P. Ariami, and E. Resnhaleksmana, “Korelasi Temuan Limfosit Plasma Biru dengan Kadar C-Reaktif Protein sebagai Penunjang dalam Diagnosis Demam Berdarah Dengue,” J. Kesehat. Andalas, vol. 11, no. 2, p. 111, Dec. 2022, doi: 10.25077/jka.v11i2.2032.
S. Khairunnisa, E. M. Hidayat, and R. Herardi, “Hubungan Jumlah Leukosit dan Persentase Limfosit terhadap Tingkat Demam pada Pasien Anak dengan Demam Tifoid di RSUD Budhi Asih Tahun 2018 – Oktober 2019,” 2020.
A. H. Tanjung, N. Nurnaningsih, and I. S. Laksono, “Jumlah Leukosit, Neutrofil, Limfosit, dan Monosit sebagai Prediktor Infeksi dengue pada Anak dengan Gizi Baik di Fasilitas Kesehatan dengan Sumber Daya Terbatas,” Sari Pediatri, vol. 17, no. 3, p. 175, Nov. 2016, doi:
14238/sp17.3.2015.175-9.
N. H. Shofaroh and S. Ardiansyah, “Comparison Of The Number Of Leukocytes, Lymphocytes, Monocytes and Neutrophils In Patients with Infectious and Non-Infectious Febriles [Perbandingan Jumlah Leukosit, Limfosit, Monosit dan Neutrofil pada Penderita Febris Infeksi dan Non Infeksi]”, doi: https://doi.org/10.21070/ups.2225.
Hidayat 1, , Hetti Rusmini2, , Toni Prasetia 3, and , Henri Setiawan4, “Jumlah Leukosit dan Derajat Klinis Penderita Infeksi Dengue di RSUD DR. H. ABDUL MOELOEK LAMPUNG,”
, vol. 1, no. 1, pp. 45–52, 2021, doi: https://doi.org/10.53579/jitkt.v1i1.
Mutiara Salsabila Lubis , Armon Rahimi, Hendrianto, “Analisis Jumlah Leukosit pada Penderita Demam Tifoid Usia Dewasa,” Jurnal Penelitian Inovatif (JUPIN), vol. 4, no. 4, pp. 2317–2322, Nov. 2024, doi: https://doi.org/10.54082/jupin.886.
S Cahyani1, T Rizkianti2 and T Susantiningsih3, “Hubungan Jumlah Trombosit, Nilai Hematokrit dan Rasio Neutrofil-Limfosit Terhadap Lama Rawat Inap Pasien DBD Anak di RSUD Budhi Asih Bulan Januari – September Tahun 2019,” 2020, pp. 49–60.
Mega Diahsyah Utami, Fani Ade Irma, “Hubungan Jumlah Leukosit Total dan Jumlah Trombosit Terhadap Hasil Kepositifan TUBEX-TF Pada Pasien Demam Tifoid di RSUD Dr. PIRNGADI Kota Medan Tahun 2018-2021,” Novemb. 2023, vol. 7, no. 4, pp. 336–343.
Downloads
Additional Files
Posted
License
Copyright (c) 2025 UMSIDA Preprints Server
This work is licensed under a Creative Commons Attribution 4.0 International License.
